SCHEMBL9537863

SCHEMBL9537863

Cc1nc2n(c(=O)c1CCN1CCC(Cc3nc4ccccc4n3Cc3ccc(F)cc3)CC1)CCCS2

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SSTR5 P35346 3/20 0.45
KCNH2 Q12809 5/20 0.44
HRH1 P35367 5/20 0.44
CYP2D6 P10635 4/20 0.44
CHRM1 P11229 3/20 0.44
TACR2 P21452 2/20 0.44
TACR1 P25103 2/20 0.44
EED O75530 2/20 0.44
MEN1 O00255 1/20 0.44
MLNR O43193 1/20 0.44
CACNA1F O60840 1/20 0.44
USP2 O75604 1/20 0.44
ABCB11 O95342 1/20 0.44
EGFR P00533 1/20 0.44
LMNA P02545 1/20 0.44
HLA-A P04439 1/20 0.44
ERBB2 P04626 1/20 0.44
TP53 P04637 1/20 0.44
CYP1A2 P05177 1/20 0.44
LCK P06239 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10549840 0.89 SLC6A9 (0.47) KCNH2HRH1CYP2D6CHRM1CACNA1F
SCHEMBL9535893 0.87 HTR1A (0.53) SSTR5KCNH2HRH1CYP2D6CHRM1
SCHEMBL9537922 0.86 ALDH1A1 (0.38) USP2LMNAHTR1AGAAMAPT
SCHEMBL9383006 0.83 SSTR5 (0.47) SSTR5KCNH2HRH1CYP2D6CHRM1
SCHEMBL9536711 0.82 CYP2D6 (0.59) SSTR5KCNH2HRH1CYP2D6CHRM1
SCHEMBL9537833 0.82 ALDH1A1 (0.39) USP2HTR1AGAADRD2DRD4
SCHEMBL9801715 0.79 SSTR5 (0.46) SSTR5KCNH2HRH1CYP2D6CHRM1
SCHEMBL10551137 0.78 DRD2 (0.52) KCNH2HRH1CYP2D6CHRM1CACNA1F
SCHEMBL10551226 0.78 DRD2 (0.52) KCNH2HRH1CYP2D6CHRM1CACNA1F
SCHEMBL9537270 0.77 SSTR5 (0.49) SSTR5KCNH2HRH1CYP2D6CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0151826-B1 4-[(Bicyclic heterocyclyl)-methyl and -hetero]-piperidines JANSSEN PHARMACEUTICA N.V. (BE) 1993-03-31 EP claimed